Understanding sub-national payer expectations is critical for securing market access. Companies that align evidence generation with regional decision-making can reduce delays and optimise launch outcomes. Here’s how to approach it strategically.

A successful launch isn’t just about hitting milestones—it’s about anticipating market and regulatory dynamics, aligning internal stakeholders, and making real-time decisions that maximise uptake. Here are three principles I’ve found consistently effective.

Pharmaceutical strategy is evolving faster than ever. Companies that integrate digital insights, payer expectations, and patient-centric models into their commercial planning will have a competitive edge. Here’s my perspective on where the industry is heading